As of Sep 20
| -0.05 / -1.98%|
The 4 analysts offering 12-month price forecasts for Celldex Therapeutics Inc have a median target of 6.50, with a high estimate of 10.00 and a low estimate of 3.50. The median estimate represents a +162.10% increase from the last price of 2.48.
The current consensus among 6 polled investment analysts is to Buy stock in Celldex Therapeutics Inc. This rating has held steady since September, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.